Balanced news tone
News Sentiment
KRYSTAL sentiment intelligence
KRYSTAL INTEGRATED SER L news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-0.6% over one week, +4.2% over four weeks, trend active, and near fair-value range.
Krystal Biotech (NASDAQ:KRYS) Shows High-Growth Momentum With Perfect Minervini Trend Template Setup
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Krystal Biotech (NASDAQ:KRYS) Shows High-Growth Momentum With Perfect Minervini Trend Template Setup
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 09:20
- Source
- ChartMill
Is Krystal Biotech (KRYS) Too Expensive After A 440% Return?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 02:52
- Source
- simplywall.st
ETFs Investing in Krystal Biotech, Inc. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 18:17
- Source
- TradingView
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $369.44, Implies 1% Upside
- Tone
- Positive 80/100
- Event
- Analyst action
- Published
- 13 Jul 2026 19:20
- Source
- TradingView
BofA raises Krystal Biotech stock price target on Vyjuvek growth
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 13 Jul 2026 16:13
- Source
- Investing.com
Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 06:06
- Source
- simplywall.st
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Krystal Biotech stock hits all-time high at 357.65 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Investing.com
The Brown Capital Management Small Company Fund Bets on Krystal Biotech (KRYS) for Its Resilient Revenue Stream
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Krystal Biotech, Inc. (KRYS) Stock Analysis: Evaluating the 31.9% Revenue Growth and Its Implications for Investors
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- DirectorsTalk Interviews
Is Krystal Biotech, Inc. (KRYS) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jun 2026 07:00
- Source
- Market source
Is the Options Market Predicting a Spike in Krystal Biotech Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
Krystal Biotech Stock Soars 16% in Three Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $330.56, Implies 6% Upside
- Tone
- Positive 80/100
- Event
- Analyst action
- Published
- 14 May 2026 07:00
- Source
- TradingView
Is It Too Late To Consider Krystal Biotech (KRYS) After Its Strong Share Price Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
A Look At Krystal Biotech (KRYS) Valuation After Recent Share Price Momentum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Market source
Is It Too Late To Consider Krystal Biotech (KRYS) After Strong Multi‑Year Share Gains?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Market source